| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| BPMC | Blueprint Medicines Corporation | -125,538 | Exited | 13F | ||||
| CADL | Candel Therapeutics, Inc. | -355,112 | Exited | 13F | ||||
| FATE | Fate Therapeutics, Inc. | -2,485,018 | Exited | 13F | ||||
| GBIO | Generation Bio Co. | -1,944,945 | Exited | 13F | ||||
| HOOK | HOOKIPA Pharma Inc. | -812,814 | Exited | 13F | ||||
| IGMS | IGM Biosciences, Inc. | -4,096,210 | Exited | 13F | ||||
| NMRA | Neumora Therapeutics, Inc. | -1,034,600 | Exited | 13F | ||||
| RCKT | Rocket Pharmaceuticals, Inc. | -552,079 | Exited | 13F | ||||
| VRNA | Verona Pharma plc | -223,843 | Exited | 13F | ||||
| VERV | Verve Therapeutics, Inc. | -1,691,530 | Exited | 13F |